| Date | Form | Description | Docs | XBRL | Pages |
| 06/13/00 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
14 | |
| 06/12/00 | DEF 14A | Definitive proxy statements |
|
24 | |
| 03/15/00 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
13 | |
| 02/23/00 | S-8 POS | Post-effective amendment to a S-8 registration statement |
|
9 | |
| 01/28/00 | 10-K | Annual report pursuant to section 13 and 15(d) |
|
60 | |
| 09/13/99 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
15 | |
| 07/28/99 | 8-K | Current report filing |
|
10 | |
| 06/28/99 | DEF 14A | Definitive proxy statements |
|
9 | |
| 06/17/99 | SC 13D/A | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities |
|
6 | |
| 06/14/99 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
25 |
Latest News & Events
Anixa Biosciences Initiates Dosing in Fourth Cohort in its Ovarian Cancer CAR-T Clinical Trial
Read More...Anixa Biosciences to Host an Investor Webcast on June 26, 2025
Read More...Anixa Biosciences' Breast Cancer Vaccine Receives National News Coverage
Read More...